The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma

BACKGROUND: The melanoma-specific graded prognostic assessment (msGPA) assigns patients with brain metastases from malignant melanoma to 1 of 4 prognostic groups. It was largely derived using clinical data from patients treated in the era that preceded the development of newer therapies such as BRAF...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkins, Anna, Furness, Andrew, W Corbett, Richard, Bloomfield, Adam, Porta, Nuria, Morris, Stephen, Ali, Zohra, Larkin, James, Harrington, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815790/
https://www.ncbi.nlm.nih.gov/pubmed/26484413
http://dx.doi.org/10.1038/bjc.2015.357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815790/
https://www.ncbi.nlm.nih.gov/pubmed/26484413
http://dx.doi.org/10.1038/bjc.2015.357

Ejemplares similares